rs55708318

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006017.3(PROM1):​c.1768-5C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0439 in 1,606,490 control chromosomes in the GnomAD database, including 1,781 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.035 ( 117 hom., cov: 32)
Exomes 𝑓: 0.045 ( 1664 hom. )

Consequence

PROM1
NM_006017.3 splice_region, intron

Scores

2
Splicing: ADA: 0.00001316
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8O:1

Conservation

PhyloP100: -1.27

Publications

7 publications found
Variant links:
Genes affected
PROM1 (HGNC:9454): (prominin 1) This gene encodes a pentaspan transmembrane glycoprotein. The protein localizes to membrane protrusions and is often expressed on adult stem cells, where it is thought to function in maintaining stem cell properties by suppressing differentiation. Mutations in this gene have been shown to result in retinitis pigmentosa and Stargardt disease. Expression of this gene is also associated with several types of cancer. This gene is expressed from at least five alternative promoters that are expressed in a tissue-dependent manner. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
PROM1 Gene-Disease associations (from GenCC):
  • retinal macular dystrophy type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa 41
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • cone-rod dystrophy 12
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Stargardt disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 4-15992396-G-A is Benign according to our data. Variant chr4-15992396-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 100578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0511 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PROM1NM_006017.3 linkc.1768-5C>T splice_region_variant, intron_variant Intron 16 of 27 ENST00000447510.7 NP_006008.1 O43490-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PROM1ENST00000447510.7 linkc.1768-5C>T splice_region_variant, intron_variant Intron 16 of 27 1 NM_006017.3 ENSP00000415481.2 O43490-1

Frequencies

GnomAD3 genomes
AF:
0.0349
AC:
5296
AN:
151776
Hom.:
117
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00946
Gnomad AMI
AF:
0.0419
Gnomad AMR
AF:
0.0358
Gnomad ASJ
AF:
0.0297
Gnomad EAS
AF:
0.000771
Gnomad SAS
AF:
0.0170
Gnomad FIN
AF:
0.0443
Gnomad MID
AF:
0.0414
Gnomad NFE
AF:
0.0526
Gnomad OTH
AF:
0.0393
GnomAD2 exomes
AF:
0.0356
AC:
8687
AN:
243794
AF XY:
0.0365
show subpopulations
Gnomad AFR exome
AF:
0.00764
Gnomad AMR exome
AF:
0.0232
Gnomad ASJ exome
AF:
0.0293
Gnomad EAS exome
AF:
0.000171
Gnomad FIN exome
AF:
0.0427
Gnomad NFE exome
AF:
0.0517
Gnomad OTH exome
AF:
0.0415
GnomAD4 exome
AF:
0.0449
AC:
65302
AN:
1454596
Hom.:
1664
Cov.:
31
AF XY:
0.0448
AC XY:
32380
AN XY:
723244
show subpopulations
African (AFR)
AF:
0.00848
AC:
279
AN:
32886
American (AMR)
AF:
0.0251
AC:
1086
AN:
43210
Ashkenazi Jewish (ASJ)
AF:
0.0295
AC:
767
AN:
25994
East Asian (EAS)
AF:
0.000354
AC:
14
AN:
39598
South Asian (SAS)
AF:
0.0196
AC:
1664
AN:
84824
European-Finnish (FIN)
AF:
0.0421
AC:
2246
AN:
53356
Middle Eastern (MID)
AF:
0.0536
AC:
307
AN:
5726
European-Non Finnish (NFE)
AF:
0.0509
AC:
56450
AN:
1108934
Other (OTH)
AF:
0.0414
AC:
2489
AN:
60068
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
2760
5520
8280
11040
13800
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2038
4076
6114
8152
10190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0349
AC:
5294
AN:
151894
Hom.:
117
Cov.:
32
AF XY:
0.0345
AC XY:
2558
AN XY:
74230
show subpopulations
African (AFR)
AF:
0.00946
AC:
392
AN:
41446
American (AMR)
AF:
0.0358
AC:
546
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.0297
AC:
103
AN:
3472
East Asian (EAS)
AF:
0.000773
AC:
4
AN:
5174
South Asian (SAS)
AF:
0.0170
AC:
82
AN:
4816
European-Finnish (FIN)
AF:
0.0443
AC:
464
AN:
10476
Middle Eastern (MID)
AF:
0.0377
AC:
11
AN:
292
European-Non Finnish (NFE)
AF:
0.0526
AC:
3572
AN:
67942
Other (OTH)
AF:
0.0389
AC:
82
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
265
529
794
1058
1323
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0463
Hom.:
306
Bravo
AF:
0.0317
EpiCase
AF:
0.0515
EpiControl
AF:
0.0559

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3Other:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
NEI Ophthalmic Genomics Laboratory, National Institutes of Health
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Jul 18, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Stargardt disease 4 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Retinal macular dystrophy type 2 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Cone-rod dystrophy 12 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Retinitis pigmentosa Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.48
DANN
Benign
0.32
PhyloP100
-1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000013
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.14
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55708318; hg19: chr4-15994019; API